Home › Funds › NEA Management Company, LLC › TRVI
NEA Management Company, LLC position in TRVI
TREVI THERAPEUTICS INC · Health Care
NEA Management Company, LLC reported holding 13,222,228 shares of TRVI (TREVI THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$189.3M, representing 13.88% of its reported portfolio and ranking #3 among its reported holdings. NEA Management Company, LLC has disclosed TRVI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How NEA Management Company, LLC's TRVI position evolved
NEA Management Company, LLC first disclosed a stake in TRVI in Q3 2023 at 11,370,376 shares (US$24.8M). The position peaked in Q2 2026 at 13,222,228 shares, worth US$246.6M. Across 13 filings, NEA Management Company, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 13,222,228 shares valued at US$189.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 11.37M | $24.79M | New |
| Q4 2023 | 11.37M | $15.24M | Hold |
| Q1 2024 | 11.37M | $39.23M | Hold |
| Q2 2024 | 11.37M | $33.88M | Hold |
| Q3 2024 | 11.37M | $37.98M | Hold |
| Q4 2024 | 11.37M | $48.85M | Hold |
| Q1 2025 | 11.37M | $71.52M | Hold |
| Q2 2025 | 13.22M | $72.33M | Add |
| Q3 2025 | 13.22M | $120.98M | Hold |
| Q4 2025 | 13.22M | $165.54M | Hold |
| Q1 2026 | 13.22M | $157.74M | Hold |
| Q2 2026 | 13.22M | $246.59M | Hold |
| Q3 2026 | 13.22M | $189.34M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TRVI and 13F data
TRVI (TREVI THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in TRVI — the largest reported positions include Frazier Life Sciences Management, L.P. (US$136.6M), Vivo Capital, LLC (US$60.6M), MPM BioImpact LLC (US$42.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TRVI
- Frazier Life Sciences Management, L.P. 9.54M sh · $136.60M · Q3 2026
- Vivo Capital, LLC 4.23M sh · $60.57M · Q3 2026
- MPM BioImpact LLC 2.98M sh · $42.66M · Q3 2026
- Soleus Capital Management, L.P. 2.73M sh · $39.06M · Q3 2026
- First Light Asset Management, LLC 2.39M sh · $34.19M · Q3 2026
- Artia Global Partners LP 2.21M sh · $31.66M · Q3 2026
- ACORN CAPITAL ADVISORS, LLC 2.14M sh · $30.71M · Q3 2026
- Affinity Asset Advisors, LLC 1.80M sh · $25.78M · Q3 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.74M sh · $24.96M · Q3 2026
- Saturn V Capital Management LP 1.57M sh · $22.54M · Q3 2026
- Siren, L.L.C. 1.52M sh · $21.82M · Q3 2026
- Vestal Point Capital, LP 1.50M sh · $21.41M · Q3 2026
More on NEA Management Company, LLC
FAQ
How long has NEA Management Company, LLC held TRVI?
NEA Management Company, LLC has disclosed TRVI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is NEA Management Company, LLC's current position in TRVI?
As of Q3 2026, NEA Management Company, LLC holds 13.22M shares of TRVI (TREVI THERAPEUTICS INC), valued at $189.34M, representing 13.88% of its reported portfolio and ranking #3.
Has NEA Management Company, LLC been buying or selling TRVI?
In the latest 13F filing (Q3 2026), NEA Management Company, LLC held unchanged its position in TRVI. The position peaked in Q2 2026 at 13.22M shares.
Which other funds hold TRVI?
Other major institutional holders of TRVI include Frazier Life Sciences Management, L.P., Vivo Capital, LLC, MPM BioImpact LLC, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.